Lei Zhao

4PUBLICATIONS
16CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 01, 2026
Integrated single-cell multi-omics characterization reveals lipid-associated macrophage-mediated immunosuppression in neoadjuvant immunotherapy of hepatocellular carcinoma.

|Mar 04, 2025
Systemic Treatment for Unresectable Hepatocellular Carcinoma: A Surgeon's Perspective.

Xiao-Dong Zhu, Lei Zhao, Binkui Li

|Apr 16, 2024
Neoadjuvant tislelizumab plus stereotactic body radiotherapy and adjuvant tislelizumab in early-stage resectable hepatocellular carcinoma: the Notable-HCC phase 1b trial.

Zhongchao Li, Jing Liu, Bo Zhang

|Sep 17, 2022
Protocol of notable-HCC: a phase Ib study of neoadjuvant tislelizumab with stereotactic body radiotherapy in patients with resectable hepatocellular carcinoma.

Bo Zhang, Jinbo Yue, Xuetao Shi

Pageof 1

Frequent Collaborators

1 joint publications

Zhongchao Li

1 joint publications

Bo Zhang

1 joint publications

Xuetao Shi

1 joint publications

Kai Cui